Goat Anti-Human IgG Fc (FITC) (ab97224)
Key features and details
- Goat Anti-Human IgG Fc (FITC)
- Conjugation: FITC. Ex: 493nm, Em: 528nm
- Host species: Goat
- Isotype: IgG
- Suitable for: IHC-P, ICC/IF
Related conjugates and formulations
Overview
-
Product name
Goat Anti-Human IgG Fc (FITC)
See all IgG secondary antibodies -
Host species
Goat -
Target species
Human -
Specificity
By immunoelectrophoresis and ELISA this antibody reacts specifically with Human IgG. Cross reactivity with other immunoglobulins and light chains is less than 0.1%. -
Tested applications
Suitable for: IHC-P, ICC/IFmore details -
Immunogen
Other Immunogen Type corresponding to Human IgG.
-
Conjugation
FITC. Ex: 493nm, Em: 528nm
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C. -
Storage buffer
pH: 6.80
Preservative: 0.09% Sodium azide
Constituents: 0.2% BSA, 99% PBS -
Concentration information loading... -
Purity
Immunogen affinity purified -
Purification notes
Antiserum was solid phase adsorbed to ensure class specificity. This antibody was isolated by affinity chromatography using antigen coupled to agarose beads and conjugated to FITC. -
Clonality
Polyclonal -
Isotype
IgG -
Research areas
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab97224 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Abreviews | Notes |
|---|---|---|
| IHC-P |
1/50 - 1/500.
|
|
| ICC/IF |
1/50 - 1/500.
|
| Notes |
|---|
|
IHC-P
1/50 - 1/500. |
|
ICC/IF
1/50 - 1/500. |
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
Datasheets and documents
-
SDS download
-
Datasheet download
References (7)
ab97224 has been referenced in 7 publications.
- Seephetdee C et al. Mice Immunized with the Vaccine Candidate HexaPro Spike Produce Neutralizing Antibodies against SARS-CoV-2. Vaccines (Basel) 9:N/A (2021). PubMed: 34066016
- Zhou X et al. Case Report: A Re-Positive Case of SARS-CoV-2 Associated With Glaucoma. Front Immunol 12:701295 (2021). PubMed: 34394095
- Zhao XH et al. Clinical features and outcomes of Chinese patients with anti-?-aminobutyric acid B receptor encephalitis. Exp Ther Med 20:617-622 (2020). PubMed: 32509023
- Liu W et al. Structural Basis of CD160:HVEM Recognition. Structure 27:1286-1295.e4 (2019). PubMed: 31230945
- Hamorsky KT et al. Engineering of a Lectibody Targeting High-Mannose-Type Glycans of the HIV Envelope. Mol Ther 27:2038-2052 (2019). PubMed: 31471224
- Lee CH et al. IgG Fc domains that bind C1q but not effector Fc? receptors delineate the importance of complement-mediated effector functions. Nat Immunol 18:889-898 (2017). PubMed: 28604720
- Li JQ et al. Generation of induced pluripotent stem cells using skin fibroblasts from patients with myocardial infarction under feeder-free conditions. Mol Med Rep 9:837-42 (2014). PubMed: 24398533